The animal studies are promising but early research in humans show mixed results. Here’s what we know so far.
Academic rigor, journalistic flair
Articles on GLP-1
Displaying all articles
Does weight come back when you stop taking drugs like Ozempic? Are these medications simply another (expensive) form of yo-yo dieting? Here’s what we know so far.
We don’t tell people taking statins to treat high cholesterol or drugs to manage high blood pressure they’re cheating or taking the easy way out. Nor should we when people take drugs like Ozempic.
Many have declared drugs like Ozempic could ‘end obesity’. This isn’t just untrue – it also perpetuates fat stigma.
In Australia, Ozempic is only approved to treat diabetes but doctors are prescribing it ‘off label’ for weight loss. Compounding pharmacies have also been making their own versions to meet demand.
Ozempic generated A$21 billion of sales in 2023 alone. So how was it developed? And how are its new competitors, Mounjaro and Zepbound, different?
Early on we heard a lot about the potential benefits of drugs like Ozempic. Now we’re hearing more about the risks. But what does the latest evidence say?
The first-ever imaging and recording of a brainstem structure critical for feeling full could help reveal exactly how weight loss drugs like Ozempic work, and how to make them more effective.
Weight loss and diabetes drugs target regulatory pathways involved in metabolism that the microbes in your gut and certain molecules from food already play a key role in regulating.
Top contributors
-
ARC Future Fellow, School of Biomedical Sciences, The University of Queensland
-
Professor of Community Health and Wellbeing, The University of Queensland
-
Lecturer, Southern Cross University
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Associate Lecturer, Sydney Pharmacy School, University of Sydney
-
Lecturer Pharmacy Practice, University of Sydney
-
Adjunct Senior Lecturer, Nutrition, Dietetics & Food Innovation - School of Health Sciences, UNSW Sydney
-
Laureate Professor in Nutrition and Dietetics, University of Newcastle
-
General Practitioner, PhD Candidate, Bond University
-
Addiction Psychiatrist, Associate Professor, Monash University
-
Florey Institute of Neuroscience and Mental Health
-
The University of Melbourne
-
Associate Professor of Gastroenterology, School of Medicine, University of Washington
-
Professor of Physiology, Kavli Institute for Fundamental Neuroscience, University of California, San Francisco
